Especially when the tumor cells are diffused or clustered, and at the same time do not completely resemble lobular carcinoma or non-specific invasive carcinoma, not only E-Cadherin but also LCA should be added into the IHC panel. Here, PTPRC is linked to invasive carcinoma.